Aleva Neurotherapeutics' Series C Round

Aleva Neurotherapeutics raised a round of funding on May 27, 2016.

Aleva Neurotherapeutics develops next-generation implants for Deep Brain Stimulation (DBS) therapy that are designed to be versatile, more precise and efficient than currently available DBS approaches…

Articles about Aleva Neurotherapeutics' Series C Round: